Activeportfolio|MassGeneralBrighamVentures

Active portfolio

Active portfolio in the news

7 days ago

Verve Therapeutics Announces Pricing of Initial Public Offering

Verve Therapeutics is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment...

Jun 1

Gene editing biotech Verve indicates a swift swerve onto Wall Street, asking for $100M IPO

Verve Therapeutics, on the march toward the clinic with a next-gen heart drug, wants a piece of the ever-growing biotech IPO pie.

May 18

Amolyt Pharma to Present New Phase 1 Data on AZP-3601-

Amolyt Pharma to Present New Phase 1 Data on AZP-3601, its Parathyroid Hormone Analog for Hypoparathyroidism, and Preclinical Data on AZP-34

Apr 30

Looking to reinvent those troubled AAVs you've been reading about...

Investors back a $110M reboot effort. Source: EndPoints News Next week, Affinia Therapeutics will present four new abstracts at the...

Apr 18

Lyndra Therapeutics Presents Promising Phase 2 Data on Once-Weekly Oral Risperidone Treatment

Lyndra Therapeutics Presents Promising Phase 2 Data on Once-Weekly Oral Risperidone Treatment, LYN-005, in Development for Schizophrenia

Mar 22

Amolyt Pharma Presents First Clinical Data for AZP-3601

ZP-3601 - Its Parathyroid Hormone Analog for Hypoparathyroidism, at the Endocrine Society’s Virtual Annual Meeting (ENDO 2021) LYON,...

Mar 19

Mediar Therapeutics Adds New Investors As It Advances Anti-Fibrotic Treatments

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mediar Therapeutics today announced the completion of a seed extension funding round and welcomed...

Feb 17

Affinia Therapeutics Announces Addition of Gene Therapy

Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally designed adeno-associated virus (AAV)

Jan 19

Verve Therapeutics Secures $94 Million in Series B Financing to Advance Pipeline

Proceeds Support Advancement of VERVE-101 toward Clinical Initiation in 2022 CAMBRIDGE, Mass. — January 19, 2021 — Verve Therapeutics, a...

Jan 7

Scorpion Therapeutics strikes major $162M funding round for 'precision oncology 2.0'

Less than three months after breaking cover with an impressive $102 million series A, Scorpion has whipped up another major funding round...

Jan 7

Abcuro will take an anti-KLRG1 antibody into the clinic with new funding...

A little over two years after pulling in its first Series A raise, autoimmune disease and cancer player Abcuro has some more cash to play...

Jan 6

Amolyt Pharma Receives Orphan Drug Designation for AZP-3601

LYON, France and CAMBRIDGE, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing...

Jan 6

Amolyt Pharma Receives Orphan Drug Designation for AZP-3601 for the Potential Treatment of Hypoparat

Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and metabolic diseases, today announced

Dec 9, 2020

ZielBio Appoints Dieter Weinand Executive Chair

ZielBio, Inc., an early-stage biotechnology company discovering new treatments for cancer and other serious diseases through its ...

Dec 8, 2020

Amolyt Pharma Announces Research Collaboration with PeptiDream

Amolyt and Peptidream will collaborate to optimize and evaluate growth hormone receptor antagonists to select a candidate for clinical....

Oct 26, 2020

Scorpion Therapeutics debuts with $108M to 'put the sting in cancer'

When Gary Glick, Ph.D., left the CEO post at IFM Therapeutics, he didn’t know what was next. But he soon found himself on a plane with...

Oct 14, 2020

Amolyt Pharma Doses First Subject in Phase 1 Clinical Trial of Parathyroid Hormone Analog, AZP-3601

LYON, France, and NEWTON, MA, October 14, 2020 (GLOBE NEWSWIRE) — Amolyt Pharma, a global clinical-stage company specialized in...

Oct 6, 2020

Walden Biosciences Launches to Transform the Treatment of Kidney Disease28

Focused on Developing First-in-Class, Targeted Therapies to Reverse the Progression of Rare and Common Forms of Kidney Disease $51M...

Oct 1, 2020

BIAL Goes Global w/ New US Research Center and Acquisition of Promising Parkinson's Disease Program

BIAL Biotech to be based in Cambridge, Massachusetts and will be a Research Center of Excellence dedicated to genetically-defined...

Sep 1, 2020

Nocion Therapeutics Advances to Clinical Stage and Expands Leadership

First Subject Dosed in a Phase 1 Trial Evaluating NOC-100, a Novel Therapeutic for Cough Christopher Silber hired as Chief Medical...

{"items":["60cb386a95d75a0015d1ee7c","60b67fd81ed2ff001547c9ae","60a3b51f31e29c00154fbd75","608ff1ddaabf4a0015c081ca","60816cb1bbd4be0015e57ca1","605cd1c57e54690015ddba39","6054a6e765d4d90058de676b","6053578449a8c1006d2d9539","6054ab2045712500154767d0","60535ac8ac30f20015818779","60535a5e9f72f1002bdf8970","6054a65c35bb6a0016b5d1d2","60535b1c4a7abf001523052a","60535e3050eaf50015c64bda","60536354bda95500158302e2","60536487f9d1260015f313c6","605365087cb70300152c5411","605365d523dbad0015239407","605366386ac7db0015d42836","60536697fab452001641165c"],"styles":{"galleryType":"Columns","groupSize":1,"showArrows":true,"cubeImages":true,"cubeType":"max","cubeRatio":1.7777777777777777,"isVertical":true,"gallerySize":30,"collageAmount":0,"collageDensity":0,"groupTypes":"1","oneRow":false,"imageMargin":32,"galleryMargin":0,"scatter":0,"rotatingScatter":"","chooseBestGroup":true,"smartCrop":false,"hasThumbnails":false,"enableScroll":true,"isGrid":true,"isSlider":false,"isColumns":false,"isSlideshow":false,"cropOnlyFill":false,"fixedColumns":0,"enableInfiniteScroll":true,"isRTL":false,"minItemSize":50,"rotatingGroupTypes":"","rotatingCropRatios":"","columnWidths":"","gallerySliderImageRatio":1.7777777777777777,"numberOfImagesPerRow":3,"numberOfImagesPerCol":1,"groupsPerStrip":0,"borderRadius":0,"boxShadow":0,"gridStyle":0,"mobilePanorama":false,"placeGroupsLtr":true,"viewMode":"preview","thumbnailSpacings":4,"galleryThumbnailsAlignment":"bottom","isMasonry":false,"isAutoSlideshow":false,"slideshowLoop":false,"autoSlideshowInterval":4,"bottomInfoHeight":0,"titlePlacement":"SHOW_BELOW","galleryTextAlign":"center","scrollSnap":false,"itemClick":"nothing","fullscreen":true,"videoPlay":"hover","scrollAnimation":"NO_EFFECT","slideAnimation":"SCROLL","scrollDirection":0,"scrollDuration":400,"overlayAnimation":"FADE_IN","arrowsPosition":0,"arrowsSize":23,"watermarkOpacity":40,"watermarkSize":40,"useWatermark":true,"watermarkDock":{"top":"auto","left":"auto","right":0,"bottom":0,"transform":"translate3d(0,0,0)"},"loadMoreAmount":"all","defaultShowInfoExpand":1,"allowLinkExpand":true,"expandInfoPosition":0,"allowFullscreenExpand":true,"fullscreenLoop":false,"galleryAlignExpand":"left","addToCartBorderWidth":1,"addToCartButtonText":"","slideshowInfoSize":200,"playButtonForAutoSlideShow":false,"allowSlideshowCounter":false,"hoveringBehaviour":"NEVER_SHOW","thumbnailSize":120,"magicLayoutSeed":1,"imageHoverAnimation":"NO_EFFECT","imagePlacementAnimation":"NO_EFFECT","calculateTextBoxWidthMode":"PERCENT","textBoxHeight":100,"textBoxWidth":200,"textBoxWidthPercent":50,"textImageSpace":10,"textBoxBorderRadius":0,"textBoxBorderWidth":0,"loadMoreButtonText":"","loadMoreButtonBorderWidth":1,"loadMoreButtonBorderRadius":0,"imageInfoType":"ATTACHED_BACKGROUND","itemBorderWidth":1,"itemBorderRadius":0,"itemEnableShadow":false,"itemShadowBlur":20,"itemShadowDirection":135,"itemShadowSize":10,"imageLoadingMode":"BLUR","expandAnimation":"NO_EFFECT","imageQuality":90,"usmToggle":false,"usm_a":0,"usm_r":0,"usm_t":0,"videoSound":false,"videoSpeed":"1","videoLoop":true,"jsonStyleParams":"","gallerySizeType":"px","gallerySizePx":300,"allowTitle":true,"allowContextMenu":true,"textsHorizontalPadding":-30,"itemBorderColor":{"value":"rgba(0,58,150,1)"},"showVideoPlayButton":true,"galleryLayout":2,"calculateTextBoxHeightMode":"MANUAL","textsVerticalPadding":-15,"targetItemSize":300,"selectedLayout":"2|bottom|1|max|true|0|true","layoutsVersion":2,"selectedLayoutV2":2,"isSlideshowFont":true,"externalInfoHeight":100,"externalInfoWidth":0},"container":{"width":981,"galleryWidth":1013,"galleryHeight":0,"scrollBase":0,"height":null}}